178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
CRISPR screen identifies new anti-inflammatory drug target

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf
CRISPR reveals the secret life of antimicrobial peptides

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant
Study finds TNF blockers are not associated with poor pregnancy outcomes

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti
Updated guidelines released for management of atopic dermatitis

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna
Canadian wildfire smoke associated with increased asthma cases in NYC

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York
Can science take the STING out of runaway inflammation?

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res
Trial data underpins FDA approval of omalizumab for food allergy

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo
Study reveals way to predict side-effect risk from common immune suppressant medication

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s
Research explores environmental pollutant BPA and asthma susceptibility in mice

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered
Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these
SRC-3 is a novel regulator of human immune T regulatory cells

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.